Dietary Iron Supplementation Enhances DSS-Induced Colitis and Associated Colorectal Carcinoma Development in Mice
- 582 Downloads
Chronic ulcerative colitis (UC) patients frequently require iron supplementation to remedy anemia due to blood loss. However, the effect of iron supplementation on UC-associated carcinogenesis is unknown. In this study, the effect of an iron-enriched diet on dextran sulfate sodium-induced acute and chronic colitis in mice was assessed. In a short-term study, mice administered 1% DSS in the drinking fluid and an AIN76A diet containing increasing levels of iron exhibited dose-dependent increases in the severity of acute UC as compared to mice fed a control diet. A marked increase in iron deposition on the epithelial surface of the colon and in the inflamed areas and immunostaining for iNOS and nitrotyrosine were observed in the animals supplemented with diets containing different levels of iron. In a long-term carcinogenesis experiment, a twofold iron-enriched diet significantly increased colorectal tumor incidence (14/16, 88%) as compared with animals fed the control diet (3/16, 19%; P < 0.001). The present findings have implications for the management of human UC and suggest that dietary iron can enhance UC and its associated carcinogenesis by augmenting oxidative and nitrosative stress.
Unable to display preview. Download preview PDF.
- 5.Meeting Report: Molecular mechanism for inflammationpromoted pathogenesis of cancer-the sixteenth international symposium of the Sapporo cancer seminar. Cancer Res 57:3620–3623, 1997Google Scholar
- 6.Barrison IG, Roberts PD, Kane SP: Oral or parenteral iron treatment in chronic ulcerative colitis? Br Med J (Clin Res Ed) 282:514, 1981Google Scholar
- 8.Blake D, Bacon PA: The importance of iron in rheumatoid arthritis. Lancet 1:623, 1982Google Scholar
- 15.Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A: Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, ?-catenin, and p53 expression and the role of inflammation. Carcinogenesis 21:757–768, 2000PubMedGoogle Scholar
- 20.Yang G-Y, Wang ZY, Kim S, Liao J, Seril DN, Chen XX, Smith TJ, Yang CS: Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneinduced lung tumorigenesis model with A/J mice. Cancer Res 57:889–1894, 1997Google Scholar
- 22.Konijn A: Iron metabolism in inflammation. Bailliere's Clin Haematol 7:829–849, 1994Google Scholar
- 26.Reynolds PD, Middleton SJ, Hansford GM, Hunter JO: Nitric oxide in ulcerative colitis. Lancet 345:448–449, 1995Google Scholar
- 30.Schmidt C, Baumeister B, Kipnowski J, Schiermeyer-Dunkhase B, Vetter H: Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease. Hepato-Gastroenterol 43:1508–1512, 1996Google Scholar
- 33.Heimann TM, Oh AC, Martinelli G, Szporn A, Luppescu N, Lembo CA, Kurtz RJ, Fasy TM, Greenstein AJ: Colorectal carcinoma associated with ulcerative colitis: A study of prognostic indicators. Am J Surg 164:3–17, 1992Google Scholar